NXTC

NextCure, Inc.

NasdaqGSUSDEQUITY DELAYED

6.29

▲ 0.04 (0.64%)

MARKET · —

Price

Open

6.25

Prev close

6.25

Day high

6.58

Day low

6.19

Volume

36.36K

Market cap

—

P/E (TTM)

—

52W range

1.55 – 15.74

Trailing performance

Price return · vs SPY

Returnvs SPY

-23.39% -22.0%

+50.48% +46.7%

-38.33% -41.4%

-54.19% -65.3%

YTD

-55.67% -68.0%

+22.61% +2.6%

-69.17% -143.3%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

7.19

-12.53% from price

SMA 20

6.18

+1.86% from price

SMA 50

4.25

+48.17% from price

SMA 100

6.57

-4.22% from price

SMA 200

9.23

-31.87% from price

EMA 12

6.63

-5.10% from price

EMA 26

5.96

+5.47% from price

EMA 50

5.64

+11.56% from price

RSI (14)

53.0

Neutral

MACD (12,26,9)

0.66

Hist -0.10

ATR (14)

0.98

15.53% of price

Realised vol 30D

355.2%

Annualised

Bollinger upper

8.60

20, 2σ

Bollinger lower

3.75

20, 2σ

50 / 200 cross

Death

4.25 vs 9.23

Trend bias

Below 200

-31.87%

Risk profile

Daily returns · 1Y window

Beta vs SPY

2.02

More volatile than market

Correlation to SPY

0.11

Largely independent

Realised vol 30D

355.2%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-88.8%

Peak to trough

Max drawdown 5Y

-98.5%

Peak to trough

ATR 14

0.98

15.53% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 6.29

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

NXTC · links out to the publisher

Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 PR Newswire · 12d ago NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results GlobeNewswire · 16d ago Top Premarket Decliners MT Newswires · 38d ago Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · 39d ago Top Midday Gainers MT Newswires · 39d ago Sector Update: Healthcare Stocks Fall Tuesday Afternoon MT Newswires · 39d ago BC-Most Active Stocks Associated Press · 39d ago Sector Update: Healthcare Stocks Mixed Premarket Tuesday MT Newswires · 39d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.